Category: Legal-Health
-
FDA & EMA: Regulatory Bodies and Their Stand Vs. Bladder Cancer Risk
0 Likes Thank You! The European Medicines Agency (EMA) seemed to tilt toward the direction taken by the Food and Drugs Administration (FDA) regarding Actos (pioglitazone) bladder cancer risk. With the move of France to suspend sales
-
The Google Street View Project Saga: Another Episode of Privacy Controversy
0 Likes Thank You! The Google Street View project started as a promising platform. An innovative technology for Google Maps and Google Earth, Google Street View offers close-to-reality views of streets of select countries around the world.
-
Actos Bladder Cancer Lawsuits Continue to Increase
0 Likes Thank You! As the first hearing for the Actos (pioglitazone) multidistrict litigation (MDL) approaches, more diabetics who developed bladder cancer due to the drug start filing lawsuits. In the string of latest Actos lawsuits, a
-
Two Louisiana Plaintiffs file Charges Vs. Takeda
0 Likes Thank You! Two more charges of misrepresentation were filed against Takeda in now the center of the Actos multidistrict litigation (MDL), the state of Louisiana. Plaintiffs from Louisiana accused Actos maker Takeda of willfully suppressing
-
From State to Federal Court: A Case of Actos Bladder Cancer Lawsuit in California
0 Likes Thank You! As the Actos bladder cancer multidistrict litigation (MDL) move forward, cases pending before state courts were shaken up with some jumping over the federal court. This has been the case for a lawsuit